News

Scientists at The Pirbright Institute have taken a major step forward in tackling one of the world’s most dangerous viruses, the Nipah virus, by evaluating vaccine candidates for pigs.

Using gene therapy to treat hereditary deafness is safe and effective in both children and adults, according to new findings from a multicenter clinical trial.

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a phase 1 clinical trial has shown.

Scientists have developed a novel method to generate billions of rare immune cells known as conventional type I dendritic cells (cDC1s), potentially paving the way for a new class of off-the-shelf cellular cancer vaccine.

Scientists have used a precise form of gene editing, prime editing, to target the underlying mutations behind the rare neurological disorder, alternating hemiplegia of childhood.

The respiratory syncytial virus (RSV) vaccine, introduced across the UK in late summer 2024, led to a 72% reduction in babies hospitalised with the virus if mothers were vaccinated, a new study has found.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.

Researchers show that tweaking the structure of the ionizable lipid, a key component of the lipid nanoparticles that deliver mRNA, not only reduces inflammation but also boosts vaccine effectiveness.

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

Once injected into the bloodstream, the antibody TMAB3, combined with a type of RNA that stimulates an innate immune reaction, can localize to tumors and penetrate and destroy stubborn diseased cells.